Researchers at the University of North Carolina at Chapel Hill won a $1.8 million grant from the National Institutes of Health to develop an implantable drug delivery system for sustained HIV-prevention. The team said it plans to develop an injectable system that steadily releases pre-exposure prophylaxis over long periods of time. The injectable compound is […]
Funding Roundup
BioClin Therapeutics raises $30m to advance antibody-drug combo therapy
BioClin Therapeutics said yesterday that it closed a $30 million Series B round led by new investors Sofinnova Ventures and Ysios Capital. Existing investors HealthCap, Life Sciences Partners and Tekla Capital Management also invested. The company plans to use the newly-acquired funds to advance its lead candidate, B-701, as a treatment for metastatic bladder cancer in […]
Tandem Diabetes Care prices $22.5m public offering
Tandem Diabetes Care (NSDQ:TNDM) today announced the pricing details of a $22.5 million underwritten public offering. The company priced 18 million shares of its common stock at $1.25 apiece. Tandem also gave underwriters a 30-day option to buy up to an additional 2.7 million shares of common stock at the public offering price. The offering is expected […]
Ivenix pulls down $10m tranche in $50m round
Ivenix raised $10 million in equity from 18 unnamed investors in the 1st tranche of its $50 million round, according to regulatory filings. The company indicated that it does not expect the offering to exceed 1 year. It has not made a formal statement about how it plans to spend the newly-acquired funds. The Massachusetts-based start-up […]
Cohero Health oversubscribes Series A for connected respiratory tech
Cohero Health said today that it oversubscribed its $9 million Series A round with investments from Samsung Next and Omron Healthcare The latest contributions will be used to support commercialization of hardware and software for its BreatheSmart connected respiratory disease management platform, the N.Y.-based company said. “BreatheSmart from Cohero Health provides both connected hardware and software as […]
Tandem looks to raise $50m in public offering; shares fall despite Q4 earnings win
Shares in Tandem Diabetes Care (NSDQ:TNDM) fell today, although the medical device maker met expectations on Wall Street with its 4th quarter results. The San Diego-based company posted losses of -$15.7 million, or -48¢ per share, on sales of $24.8 million for the 3 months ended Dec. 31, for bottom-line loss of -40% on sales loss […]
Pacira prices $300m senior notes offering
Pacira Pharmaceuticals (NSDQ:PCRX) said today that it priced $300 million of convertible 2.375% senior notes due 2022 in a private placement to qualified institutional buyers. The Parsippany, N.J.-based company also gave purchasers a 30-day option to buy an additional $45 million aggregate principal amount of notes. The company expects to bring in about $290 million […]
Bristol-Myers prices $1.5B senior notes offering
Bristol-Myers Squibb (NYSE:BMY) said today that it has agreed to sell $1.5 billion of senior unsecured notes in an underwritten public offering. The offering includes $750 million in 1.6% senior notes due in 2019 and $750 million in 3.3% senior notes due in 2027, according to the New York-based company. Bristol-Myers said it plans to […]
JDRF backs GluSense with $2m grant
GluSense said yesterday that it received a $2 million grant from the Juvenile Diabetes Research Foundation’s T1D fund for the company’s injectable glucose sensor. Israel-based GluSense, part of Rainbow Medical, is developing the Glyde continuous glucose monitor for patients with Type I diabetes. The device is injected under the skin and lasts for 1 year, […]
Biostage prices $8m offering for bioengineered organ implant
Biostage (NSDQ:BSTG), a 27-person biotech based in Holliston, Mass., is developing technology to regrow esophageal tissue in patients that have esophageal cancer or atresia. Last week, the company priced a public offering at ¢40 per share of common stock, expecting to bring in $8 million from the round. The current standard of care for resectable […]